Vertaling van "hyprtension in high risk patients " (Frans → Nederlands) :

Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B et al. Benazepril plus amlodipine or hydrochlorothiazide for hyprtension in high risk patients.
Minerva 2010; 9:88-9. Bespreking van: Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B et al. Benazepril plus amlodipine or hydrochlorothiazide for hyprtension in high risk patients.

54% of referred patients were excluded from the trial and sent directly forward to PCAS because they had a „prohibitive high risk‰. 38 It is unclear who this population might conceivably be, as the risk in the SAPPHIRE trial is low compared to the NASCET and ACE (CEA-) trials.
54% of referred patients were excluded from the trial and sent directly forward to PCAS because they had a „prohibitive high risk‰.38 It is unclear who this population might conceivably be, as the risk in the SAPPHIRE trial is low compared to the NASCET and ACE (CEA-) trials.

28. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients.
carotid-artery stenting versus endarterectomy in high-risk patients.

29. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.
30. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.

D’après The ALLHAT Officers and Coordinators for the ALLAHT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.
L.M.H.Wing et al.: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly.

Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.